Co-Authors
This is a "connection" page, showing publications co-authored by Peter Horby and Martin Landray.
Connection Strength
2.685
-
Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply. Lancet. 2021 07 24; 398(10297):300.
Score: 0.958
-
Hydroxychloroquine in Hospitalized Patients with Covid-19. Reply. N Engl J Med. 2021 03 04; 384(9):882.
Score: 0.929
-
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. 2020 Nov 19; 383(21):2030-2040.
Score: 0.227
-
Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021 Feb 25; 384(8):693-704.
Score: 0.223
-
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis. JAMA. 2021 08 10; 326(6):499-518.
Score: 0.060
-
Making trials part of good clinical care: lessons from the RECOVERY trial. Future Healthc J. 2021 Jul; 8(2):e243-e250.
Score: 0.060
-
Author Correction: Potential health and economic impacts of dexamethasone treatment for patients with COVID-19. Nat Commun. 2021 Mar 05; 12(1):1596.
Score: 0.058
-
Potential health and economic impacts of dexamethasone treatment for patients with COVID-19. Nat Commun. 2021 02 10; 12(1):915.
Score: 0.058
-
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020 10 06; 324(13):1330-1341.
Score: 0.057
-
Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials. Trials. 2020 Aug 24; 21(1):734.
Score: 0.056